HIGHLIGHTS
- who: Long Will It Persist? et al. from the Department of Microbiology, Faculty of Medicine and Health Sciences, SGT University, Gurugram, Haryana, India have published the research: Impact of ChAdOx1 nCoV-19 (Covishield ) Vaccination: How, in the Journal: International Journal of Microbiology of 31/05/2022
- what: This study aimed to determine the COVID-19 IgG antibodies among healthcare workers (HCWs) before and after the ChAdOx1 nCoV-19 (Covishield ) vaccination. The observation of the study showed that two doses of Covishield vaccination induce significant antispike IgG antibody among all but 11 participants over a period . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.